top
Search terms
Results 1 - 10 of 12 - ordered by :
Pages: 1 2
Ehjcvp

Mechanistically, this separates the drug from conventional anti-anginal therapies, namely beta-adrenergic antagonists, calcium channel blockers, and nitrates. [...]a haemodynamically neutral ...

European Heart Journal - Cardiovascular Pharmacotherapy, Reviews, Cian P. McCarthy, Kieran V. Mullins, David M. Kerins

Date : 01/10/2016 Item size : 282882 bytes
Ehjcvp

[...]our presence in MEDLINE will increase the visibility of, and interest for, the journal. [...]the editors and editorial board members feel very satisfied and confident for the future of the ...

European Heart Journal - Cardiovascular Pharmacotherapy, Editorials, Stefan Agewall

Date : 01/10/2016 Item size : 112617 bytes
Ehjcvp

Mean blood glucose changes in the placebo group were 0.6mmol/L (±3.1, P0.0002), 0.2 mmol/L (±2.7, P0.04), and 0.1 mmol/L (±3.0, P0.01) in the moderate, modest, and mild weight loss groups, ...

European Heart Journal - Cardiovascular Pharmacotherapy, Original Article, Sadaf Kamil, Nicholas Finer, William Philip T James, Ian D. Caterson, Charlotte Andersson, Christian Torp-Pedersen

Date : 27/09/2016
Ehjcvp

Given the burden of cardiovascular disease in patients with diabetes, the focus should shift towards cardiovascular outcome studies designed to evaluate efficacy (i.e. to determine the efficacy of a ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, Faiez Zannad, Wendy Gattis Stough, Raymond J. Lipicky, Juan Tamargo, George L. Bakris, Jeffrey S. Borer, Maria de los Angeles Alonso ...

Date : 01/07/2016 Item size : 285307 bytes
Ehjcvp

Contemporary use of ticagrelor in patients with acute coronary syndrome: insights from Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLES, Anders Sahlén, Christoph Varenhorst, Bo Lagerqvist, Henrik Renlund, Lars Wallentin, Stefan K. James, Tomas Jernberg

Date : 01/01/2016 Item size : 280123 bytes
Ehjcvp

Abstract Cardiovascular disease is the leading cause of morbidity and mortality among patients with diabetes, underscoring the importance of choosing anti-diabetic drugs that do not increase ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, R. Kumar, D. M. Kerins, T. Walther

Date : 01/01/2016 Item size : 517106 bytes
Ehjcvp

Mechanistically, this separates the drug from conventional anti-anginal therapies, namely beta-adrenergic antagonists, calcium channel blockers, and nitrates. [...]a haemodynamically neutral ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEW, Cian P. McCarthy, Kieran V. Mullins, David M. Kerins

Date : 09/12/2015
Ehjcvp

Furthermore, we report advantages and disadvantages of respiratory drugs (β2 agonists, anti-cholinergics, and corticosteroids) administration in COPD patients with CVD. cardiovascular ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, Gianluca Campo, Rita Pavasini, Simone Biscaglia, Marco Contoli, Claudio Ceconi

Date : 01/07/2015
Ehjcvp

Furthermore, even the truth changes since we perform new studies and since people challenge the truth When I was in Medical School one professor of Medicine told the class, Damn you if you treat ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Stefan Agewall

Date : 01/04/2015 Item size : 97793 bytes
Ehjcvp

Abstract Aims Non-steroidal anti-inflammatory drugs (NSAIDs) are associated with increased risk of cardiovascular disease. Non-steroidal anti-inflammatory drugs (NSAIDs)Myocardial infarctionAtrial ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLES, Anne-Marie Schjerning Olsen, Emil L. Fosbøl, Jannik Pallisgaard, Jesper Lindhardsen, Morten Lock Hansen, Lars Køber, ...

Date : 01/04/2015